New Key Statistics Module, Z-Score and F-Score
SZSE:301015 Key Ratios
Market Cap ¥ M | 11,873.61 |
Enterprise Value ¥ M | 12,093.78 |
P/E(ttm) | 17.43 |
PE Ratio without NRI | 16.71 |
Forward PE Ratio | -- |
Price/Book | 4.19 |
Price/Sales | 1.61 |
Price/Free Cash Flow | 26.27 |
Price/Owner Earnings | 19.00 |
Payout Ratio % | 0.56 |
Revenue (TTM) ¥ M | 7,538.00 |
EPS (TTM) ¥ | 1.30 |
Beneish M-Score | -2.23 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 19.60 |
y-y EBITDA Growth Rate % | 27.60 |
EV-to-EBIT | 12.13 |
EV-to-EBITDA | 12.13 |
PEG | 0.85 |
Shares Outstanding M | 525.61 |
Net Margin (%) | 9.28 |
Operating Margin % | 13.17 |
Pre-tax Margin (%) | 12.40 |
Quick Ratio | 2.07 |
Current Ratio | 2.40 |
ROA % (ttm) | 13.06 |
ROE % (ttm) | 27.32 |
ROIC % (ttm) | 25.02 |
Dividend Yield % | 3.33 |
Altman Z-Score | 5.48 |
SZSE:301015 Number of Guru Trades
SZSE:301015 Volume of Guru Trades
Gurus Latest Trades with SZSE:301015
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301015 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Qingdao Baheal Medical Inc Insider Transactions
No Available Data